• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生成并鉴定一种促甲状腺激素受体截短的甲状腺功能减退症大鼠模型。

Generation and characterization of a hypothyroidism rat model with truncated thyroid stimulating hormone receptor.

机构信息

Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China.

Translational Center for Stem Cell Research, Tongji Hospital, Department of Regenerative Medicine, Tongji University School of Medicine, Shanghai, 200065, China.

出版信息

Sci Rep. 2018 Mar 5;8(1):4004. doi: 10.1038/s41598-018-22405-7.

DOI:10.1038/s41598-018-22405-7
PMID:29507327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5838214/
Abstract

Thyroid stimulating hormone receptor (TSHR), a G-protein-coupled receptor, is important for thyroid development and growth. In several cases, frameshift and/or nonsense mutations in TSHR were found in the patients with congenital hypothyroidism (CH), however they have not been functionally studied in an animal model. In the present work, we generated a unique Tshr rat model that recapitulates the phenotypes in TSHR Y444X patient by CRISPR/Cas genome editing technology. In this rat model, TSHR is truncated at the second transmembrane domain, leading to CH phenotypes as what was observed in the patients, including dwarf, thyroid aplasia, infertility, TSH resistant as well as low serum thyroid hormone levels. The phenotypes can be reversed, at least partially, by levothyroxine (L-T4) treatment after weaning. The thyroid development is severely impaired in the Tshr rats due to the suppression of the thyroid specific genes, i.e., thyroperoxidase (Tpo), thyroglobulin (Tg) and sodium iodide symporter (Nis), at both mRNA and protein levels. In conclusion, the Tshr rat serves as a brand new genetic model to study CH in human, and will greatly help to shed light into the development of terminal organs that are sensitive to thyroid hormones.

摘要

甲状腺刺激激素受体(TSHR)是一种 G 蛋白偶联受体,对甲状腺的发育和生长很重要。在一些先天性甲状腺功能减退症(CH)患者中发现 TSHR 的移码和/或无义突变,但在动物模型中尚未对其进行功能研究。在本工作中,我们利用 CRISPR/Cas 基因组编辑技术,在大鼠中产生了一种独特的 Tshr 基因敲除模型,该模型可模拟 TSHR Y444X 患者的表型。在这种大鼠模型中,TSHR 在第二跨膜结构域截断,导致 CH 表型,如在患者中观察到的,包括矮小、甲状腺发育不全、不孕、TSH 抵抗以及血清甲状腺激素水平低。在断奶后,用左甲状腺素(L-T4)治疗可部分逆转这些表型。由于甲状腺特异性基因,即甲状腺过氧化物酶(Tpo)、甲状腺球蛋白(Tg)和钠碘转运体(Nis)的 mRNA 和蛋白水平受到抑制,Tshr 大鼠的甲状腺发育严重受损。总之,Tshr 大鼠为研究人类 CH 提供了一个全新的遗传模型,并将极大地有助于阐明对甲状腺激素敏感的终末器官的发育。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb0/5838214/b64a8ab90020/41598_2018_22405_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb0/5838214/842d05234724/41598_2018_22405_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb0/5838214/f51178ce1ccd/41598_2018_22405_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb0/5838214/8fc6cf0fa8c3/41598_2018_22405_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb0/5838214/705f6e8b49c3/41598_2018_22405_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb0/5838214/b64a8ab90020/41598_2018_22405_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb0/5838214/842d05234724/41598_2018_22405_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb0/5838214/f51178ce1ccd/41598_2018_22405_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb0/5838214/8fc6cf0fa8c3/41598_2018_22405_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb0/5838214/705f6e8b49c3/41598_2018_22405_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb0/5838214/b64a8ab90020/41598_2018_22405_Fig5_HTML.jpg

相似文献

1
Generation and characterization of a hypothyroidism rat model with truncated thyroid stimulating hormone receptor.生成并鉴定一种促甲状腺激素受体截短的甲状腺功能减退症大鼠模型。
Sci Rep. 2018 Mar 5;8(1):4004. doi: 10.1038/s41598-018-22405-7.
2
[The thyroid as a model for molecular mechanisms in genetic diseases].[甲状腺作为遗传疾病分子机制的模型]
Medicina (B Aires). 2005;65(3):257-67.
3
Functional characterization of the novel sequence variant p.S304R in the hinge region of TSHR in a congenital hypothyroidism patients and analogy with other formerly known mutations of this gene portion.先天性甲状腺功能减退症患者中促甲状腺激素受体铰链区新型序列变异p.S304R的功能特性及与该基因部分其他已知突变的类比
J Pediatr Endocrinol Metab. 2015 Jul;28(7-8):777-84. doi: 10.1515/jpem-2014-0194.
4
A novel mutation in the thyrotropin (thyroid-stimulating hormone) receptor gene in a case of congenital hypothyroidism.先天性甲状腺功能减退症一例中促甲状腺素(甲状腺刺激激素)受体基因的一种新突变。
Thyroid. 2006 Dec;16(12):1303-9. doi: 10.1089/thy.2006.16.1303.
5
Molecular screening of the TSH receptor (TSHR) and thyroid peroxidase (TPO) genes in Korean patients with nonsyndromic congenital hypothyroidism.韩国非综合征型先天性甲状腺功能减退症患者的 TSH 受体(TSHR)和甲状腺过氧化物酶(TPO)基因的分子筛查。
Clin Endocrinol (Oxf). 2011 Nov;75(5):715-21. doi: 10.1111/j.1365-2265.2011.04156.x.
6
A family with congenital hypothyroidism caused by a combination of loss-of-function mutations in the thyrotropin receptor and adenylate cyclase-stimulating G alpha-protein subunit genes.一个家族患有先天性甲状腺功能减退症,是由促甲状腺激素受体和腺苷酸环化酶刺激 G 蛋白亚基基因的功能丧失性突变共同引起的。
Thyroid. 2011 Feb;21(2):103-9. doi: 10.1089/thy.2010.0187. Epub 2010 Dec 27.
7
Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I- symporter mRNAs in dog thyroid.体内中等剂量的碘化物可抑制犬甲状腺细胞增殖以及甲状腺过氧化物酶和钠/碘同向转运体mRNA的表达。
Mol Cell Endocrinol. 1997 Aug 8;131(2):195-203. doi: 10.1016/s0303-7207(97)00108-1.
8
Inactivation of a Frameshift TSH Receptor Variant Val711Phefs*18 is Due to Acquisition of a Hydrophobic Degron.甲状腺刺激素受体变异 Val711Phefs*18 框移失活是由于获得一个疏水性降解基序。
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e265-e272. doi: 10.1210/clinem/dgaa772.
9
Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice.利用促甲状腺激素受体基因敲除小鼠定义甲状腺激素合成中促甲状腺激素依赖性和非依赖性步骤。
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15776-81. doi: 10.1073/pnas.242322099. Epub 2002 Nov 13.
10
Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism.导致甲状腺发育不全和持续性先天性甲状腺功能减退的人类促甲状腺激素受体基因突变。
J Clin Endocrinol Metab. 1997 Oct;82(10):3471-80. doi: 10.1210/jcem.82.10.4286.

引用本文的文献

1
Effect of L-thyroxine on bone biomechanical and morphometric parameters in rats.L-甲状腺素对大鼠骨骼生物力学和形态计量学参数的影响。
BMC Vet Res. 2025 May 19;21(1):358. doi: 10.1186/s12917-025-04816-7.
2
Therapeutic Potential of CRISPR/Cas in Hashimoto's Thyroiditis: A Comprehensive Review.CRISPR/Cas 在桥本甲状腺炎中的治疗潜力:全面综述。
Curr Gene Ther. 2024;24(3):179-192. doi: 10.2174/0115665232266508231210154930.
3
The transcription factor regulates pituitary development in zebrafish.转录因子调控斑马鱼垂体发育。

本文引用的文献

1
Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work.促甲状腺激素受体的结构功能特征:发挥作用的A类G蛋白偶联受体
Front Endocrinol (Lausanne). 2017 Apr 24;8:86. doi: 10.3389/fendo.2017.00086. eCollection 2017.
2
The 14th Ile residue is essential for Leptin function in regulating energy homeostasis in rat.第 14 位异亮氨酸残基对于瘦素在调节大鼠能量平衡中的功能是必需的。
Sci Rep. 2016 Jul 5;6:28508. doi: 10.1038/srep28508.
3
[Peptide 612-627 of thyrotropin receptor and its modified derivatives as the regulators of adenylyl cyclase in the rat thyroid gland].
Front Endocrinol (Lausanne). 2023 Feb 7;14:920548. doi: 10.3389/fendo.2023.920548. eCollection 2023.
4
Current understanding of epigenetics role in melanoma treatment and resistance.目前对表观遗传学在黑色素瘤治疗及耐药性中的作用的理解。
Cancer Cell Int. 2022 Oct 12;22(1):313. doi: 10.1186/s12935-022-02738-0.
5
Advances in Genome Editing and Application to the Generation of Genetically Modified Rat Models.基因组编辑进展及其在转基因大鼠模型构建中的应用
Front Genet. 2021 Apr 20;12:615491. doi: 10.3389/fgene.2021.615491. eCollection 2021.
6
Establishment and Characterization of Immortalized Miniature Pig Pancreatic Cell Lines Expressing Oncogenic K-Ras.永生化小型猪胰腺癌细胞系表达致癌性 K-Ras 的建立和鉴定。
Int J Mol Sci. 2020 Nov 21;21(22):8820. doi: 10.3390/ijms21228820.
7
Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.人类疾病和相关表型的大鼠模型:致病基因的系统清单。
J Biomed Sci. 2020 Aug 2;27(1):84. doi: 10.1186/s12929-020-00673-8.
8
Comparative distribution of somatostatin and somatostatin receptors in PTU-induced hypothyroidism.PTU 诱导甲状腺功能减退症中生长抑素和生长抑素受体的比较分布。
Endocrine. 2020 Oct;70(1):92-106. doi: 10.1007/s12020-020-02309-1. Epub 2020 Apr 25.
9
Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches.评估对甲状腺有干扰作用的化学物质:体外测试和不良结局途径方法的机遇和挑战。
Environ Health Perspect. 2019 Sep;127(9):95001. doi: 10.1289/EHP5297. Epub 2019 Sep 5.
[促甲状腺激素受体的肽段612 - 627及其修饰衍生物作为大鼠甲状腺腺嘌呤环化酶的调节剂]
Tsitologiia. 2014;56(7):526-35.
4
GT-Scan: identifying unique genomic targets.GT-Scan:识别独特的基因组靶点。
Bioinformatics. 2014 Sep 15;30(18):2673-5. doi: 10.1093/bioinformatics/btu354. Epub 2014 May 23.
5
Hearing impairment in hypothyroid dwarf mice caused by mutations of the thyroid peroxidase gene.甲状腺过氧化物酶基因突变导致的甲状腺功能减退症矮小症小鼠的听力损伤。
J Assoc Res Otolaryngol. 2014 Feb;15(1):45-55. doi: 10.1007/s10162-013-0427-7. Epub 2013 Dec 3.
6
Current loss-of-function mutations in the thyrotropin receptor gene: when to investigate, clinical effects, and treatment.促甲状腺激素受体基因目前的功能丧失性突变:何时进行检测、临床影响及治疗
J Clin Res Pediatr Endocrinol. 2013;5 Suppl 1(Suppl 1):29-39. doi: 10.4274/jcrpe.864. Epub 2012 Nov 15.
7
TSHR is the main causative locus in autosomal recessively inherited thyroid dysgenesis.促甲状腺激素受体是常染色体隐性遗传甲状腺发育不全的主要致病位点。
J Pediatr Endocrinol Metab. 2012;25(5-6):419-26. doi: 10.1515/jpem-2012-0053.
8
Frequent TSH receptor genetic alterations with variable signaling impairment in a large series of children with nonautoimmune isolated hyperthyrotropinemia.在一大系列非自身免疫性孤立性促甲状腺素(TSH)受体增高症患儿中,频繁出现 TSH 受体基因改变,伴有可变的信号转导损害。
J Clin Endocrinol Metab. 2012 Jan;97(1):E156-60. doi: 10.1210/jc.2011-1938. Epub 2011 Nov 2.
9
Nonclassic TSH resistance: TSHR mutation carriers with discrepantly high thyroidal iodine uptake.非典型 TSH 抵抗:甲状腺碘摄取明显增高的 TSHR 突变携带者。
J Clin Endocrinol Metab. 2011 Aug;96(8):E1340-5. doi: 10.1210/jc.2011-0070. Epub 2011 Jun 15.
10
Novel TSHR mutations in consanguineous families with congenital nongoitrous hypothyroidism.先天性无甲状腺肿性甲状腺功能减退症的近亲家族中 TSHR 的新突变。
Clin Endocrinol (Oxf). 2010 Nov;73(5):671-7. doi: 10.1111/j.1365-2265.2010.03849.x.